COMMUNIQUÉS West-GlobeNewswire

ZAGENO - Biotech E-commerce Platform hits 1.4 Million Products
29/12/2017
BOSTON and BERLIN, Dec. 29, 2017 (GLOBE NEWSWIRE) -- ZAGENO Inc. , the fast-growing digital marketplace for research materials, has developed an impressive portfolio, making it the first choice for purchasing and [...]
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
29/12/2017
LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]
Recro Pharma Reports Inducement Grants for New Staff
29/12/2017
MALVERN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]
Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD)
29/12/2017
– Pivotal studies to commence imminently – – Primary endpoint results and EU conditional marketing authorization submission expected in the first half of 2019 – – Company to host conference call and webcast today at 8: [...]
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
29/12/2017
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces that it has completed a prestudy visit of the Fundación [...]
Scythian Announces No Material Change
29/12/2017
TORONTO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) (“ Scythian ” or the “ Company ”) is issuing this press release in response to a request by the [...]
Helius Medical Technologies Announces Closing of Second Tranche of Private Placement
29/12/2017
NEWTOWN, Pa., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is [...]
Atara Biotherapeutics to Host Corporate Update Conference Call on Friday, December 29, 2017, at 8:00 a.m. EST
29/12/2017
– Company to announce FDA clearance to initiate two Phase 3 tabelecleucel clinical studies – SOUTH SAN FRANCISCO, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the- [...]
Retrophin to Present at the 36th Annual J.P. Morgan Healthcare Conference
28/12/2017
SAN DIEGO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Stephen Aselage, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San [...]
DAXOR CORPORATION REVISES 2017 DIVIDEND
28/12/2017
New York, NY, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, revises the record date and payment date of its 2017 [...]
Universal Suicide Screening in Hospitals Can Be Successfully Implemented
28/12/2017
OAKBROOK TERRACE, Ill., Dec. 28, 2017 (GLOBE NEWSWIRE) -- The nation’s suicide rate has been increasing over the past decade. Today, it is the 10th leading cause of death in the United States. 1 Many individuals who die [...]
University of Alabama Professor Elected to the American College of Prosthodontists Board of Directors
28/12/2017
Chicago, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daniel A. Givan, DMD, PhD, FACP , was elected as Secretary for the Board of Directors of the American College of Prosthodontists (ACP), the national organization representing [...]
Cannabix unaware of any material change
28/12/2017
VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (the “Company”) reports at the request of IIROC (Investment Industry Regulatory Organization of Canada), Cannabix [...]
UAHC Ventures, LLC reaches Settlement with MGT Capital Investments, Inc. (“MGTI”) to receive 7,001,817 shares of MGTI Common Stock
28/12/2017
CHICAGO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- UAHC Ventures, LLC, a wholly-owned subsidiary of United American Healthcare Corporation (“UAHC Ventures”), executed a Settlement Agreement on December 7, 2017 (the “Settlement [...]
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
28/12/2017
LOS ANGELES, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the treatment of vascular [...]
Green Cures & Botanical Distribution Inc. In Talks with Humboldt County Cannabis Manufacture -Cultivator
28/12/2017
Two New Board Members Join Incoming CEO LOS ANGELES, CA , Dec. 28, 2017 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body [...]
Shareholders Turn Down Tender Offer to Take BioCanCell Private
28/12/2017
JERUSALEM, Dec. 28, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, [...]
Tower One Intends to Apply for Warrant Price Reduction
28/12/2017
VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announced today that it intends to apply for a warrant [...]
Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability
28/12/2017
RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc . (“Innovate”), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory disorders, [...]

Pages